Advertisement
Research Article

An LRP5 Receptor with Internal Deletion in Hyperparathyroid Tumors with Implications for Deregulated WNT/β-Catenin Signaling

  • Peyman Björklund,

    Affiliation: Department of Surgical Sciences, Uppsala University, Endocrine Unit, Uppsala University Hospital, Uppsala, Sweden

    X
  • Göran Åkerström,

    Affiliation: Department of Surgical Sciences, Uppsala University, Endocrine Unit, Uppsala University Hospital, Uppsala, Sweden

    X
  • Gunnar Westin mail

    To whom correspondence should be addressed. E-mail: gunnar.westin@surgsci.uu.se

    Affiliation: Department of Surgical Sciences, Uppsala University, Endocrine Unit, Uppsala University Hospital, Uppsala, Sweden

    X
  • Published: November 27, 2007
  • DOI: 10.1371/journal.pmed.0040328

Reader Comments (1)

Post a new comment on this article

Publisher's Note: Correction to Figure 5C

Posted by plosmedicine on 08 May 2009 at 15:36 GMT

(C) Cotransfection of TOPFLASH and CMV-LacZ reference plasmid to sHPT-1 cells. Incubation in WNT3 and DKK1 CM.
http://plosmedicine.org/article/info:doi/10.1371/journal.pmed.0040328#pmed-0040328-g005

Due to an oversight during preparation of the manuscript, the published data of Fig. 5C showed the results of experiments done in MCF7 cells and not in sHPT-1 cells (The data on MCF7 are published in PLoS ONE 4 (1), e4243 (Fig. 4B). The correct figure in sHPT-1 cells is here: http://www.plosmedicine.org/corrections/pmed.0040328.g005.cn.tif. This oversight affects neither the data nor the conclusions of the work presented in the manuscript.

No competing interests declared.